No significant differences between treatment groups were observed using the Chao1 richness estimate 42 , which accounts for ASV rareness in the richness measure (Supplementary Fig
Yang H, Yue H-W, He W-T, Hong J-Y, Jiang L-L, Hu H-Y
Moreover, the notion that a single, common genetic variant can cause hundreds of unrelated health problems is implausible
For anyone currently on semaglutide who wants better results, mazdutide represents a mechanistic upgrade
There was no significant difference in the proportion of patients receiving oxygen therapy ( p = 1.000), antiviral therapy ( p = 0.708), antibiotics ( p = 1.000), and intravenous corticosteroids therapy ( p = 0.06) between the two groups
Additional info